(Q37763383)

22 August 2017

1 reference

title

Treatment of the primary tumor in breast cancer patients with synchronous metastases (English)

1 reference

22 August 2017

D Ali

1

1 reference

22 August 2017

R Le Scodan

series ordinal

2

1 reference

22 August 2017

publication date

7 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

22

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

9-16

1 reference

Facts and controversies in systemic treatment of metastatic breast cancer

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Association of surgery with improved survival in stage IV breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Matched pair analyses of stage IV breast cancer with or without resection of primary breast site

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Timing of surgical intervention for the intact primary in stage IV breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Effects of surgical excision on survival of patients with stage IV breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Changing indications for surgery in patients with stage IV breast cancer: a current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

The impact of prophylactic axillary node dissection on breast cancer survival--a Bayesian meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Long-term results of hypofractionated radiation therapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Palliative surgery for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Initial presentation with stage IV colorectal cancer: how aggressive should we be?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Cytoreductive surgery for advanced stages of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Evidence for immune defects in breast and lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Excisional surgery for cancer cure: therapy at a cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

The effects of surgery on tumor growth: a century of investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Primary tumor resection in stage IV breast cancer: consistent benefit, or consistent bias?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

Randomized trial comparing locoregional resection of primary tumor with no surgery in stage IV breast cancer at the presentation (Protocol MF07-01): a study of Turkish Federation of the National Societies for Breast Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ301

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDQ301

1 reference

22 August 2017

1 reference